Llorens Pharmaceutical International is categorized under in Miami, FL and active since 2001.
Llorens Pharmaceutical International was established in 2001, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Jose Hernandez, Director at the company’s single location by writing to 6852 Nw 77th Court, Miami, Florida FL 33166 or by phoning (305) 716-0595. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Llorens Pharmaceutical International |
| Contact Person: | Jose Hernandez, Director |
| Address: | 6852 Nw 77th Court, Miami, Florida 33166 |
| Phone Number: | (305) 716-0595 |
| Website Address: | llorenspharm.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 8631 |
| NAICS Code: | 3254120 |
| Share This Business: |
Llorens Pharmaceutical International was started in 2001 to provide professional under the SIC code 8631 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Jose Hernandez, Director for inquiries that concern Llorens Pharmaceutical International by calling the company number (305) 716-0595, as your correspondence is most welcome. Additionally, the physical location of the single location of Llorens Pharmaceutical International can be found at the coordinates 25.8355,-80.32242 as well as the street address 6852 Nw 77th Court in Miami, Florida 33166.
For its online presence, you may visit Llorens Pharmaceutical International’s website at llorenspharm.com and engage with its social media outlets through on Twitter and on Facebook.